News and Insights
From the Medical Affairs Experts at Zipher
September 2020
Medical Affairs Unscripted Episode 4 Now Available
As the Zipher Medical Affairs unscripted podcast series continues to distinguish Medical Affairs as one of the major pillars of biopharmaceutical organizations, Dr. Peg Crowley-Nowick, Founder & President of Zipher Medical Affairs hosts Dr. Adam Schayowitz, an industry veteran and current Vice President and Medicine Team Lead at Pfizer, to discuss the intersection between Medical Affairs (medical) and Clinical Development (development) with regards to data generation as medical continues its evolution as the third pillar in industry.
August 2020
Medical Affairs Unscripted Episode 3 Now Available
Episode 3 of Zipher’s Medical Affairs unscripted features Randi Goeckeler, an industry expert with over 25 years of experience and most recently the Executive Director of Global Stakeholder Relations at Allergan, who discusses how to build an integrated, strategic stakeholder relations program to accelerate availability of treatments for patients and ultimately help them have better outcomes.
July 2020
Medical Affairs Unscripted Episode 2 Now Available
During this episode of Medical Affairs unscripted, Dr. Crowley-Nowick has a conversation with Holly Schachner, MD, former CMO of Specialty Medicine at Allergan to examine the business objective of Medical Affairs (MA) organizations and how MA can move closer to being identified as a strategic pillar within the life sciences industry alongside the Research & Development and Commercial organizations.
June 2020
Accelerate Launch Readiness: Strategies to Stay Ahead of the Curve
During this webcast, you will learn from industry experts Peg Crowley-Nowick, PhD, MBA President of Zipher Medical Affairs Co., LLC. and Christopher Keir, MD, MS as they share key strategies for an effective and efficient approach to success in launch preparation.
Medical Affairs Unscripted Episode 1 Now Available
In this episode of Medical Affairs unscripted, President and Founder Peg Crowley-Nowick has a conversation with Dan Hennessy. They discuss reaching the right stakeholders, who they are, how important it is to engage and have scientific exchange, and what the risks are for not doing this well.
April 2020
Fostering Data Generation to Build the Value Story: An Opportunity for Medical Affairs to Move the Needle
New drugs must undergo rigorous assessments, including extensive company-sponsored clinical trials, when seeking approval. However, even with comprehensive datasets supporting regulatory application, gaps in information still exist and may adversely impact clinical and reimbursement decisions....
